Unicycive Therapeutics, Inc.

NASDAQ:UNCY

Biotechnology

Healthcare
$3.53 -3.40%

-$0.24 today

Market cap
$103.02M
Beta
1.73
P/E (TTM)
-40.8
EPS (TTM)
-$0.17
52W Low $3.71High $8.74

Volume 0.86M

Average 0.65M

Balance Sheet

Inspect the capital base behind the business.

Assets

$49.13M

FY 2025 · Annual

+55.2% YoY

Liabilities

$18.94M

FY 2025 · Annual

-21.9% YoY

Equity

$30.20M

FY 2025 · Annual

+306.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents16.58M455K9.7M26.14M29.2M
Short-term Investments000012.07M
Net Receivables00000
Inventory00000
Other Current Assets126K159K325K939K1.17M
Total Current Assets18.41M2.64M13.4M30.95M48.96M
Property, Plant & Equipment (Net)333K174K792K720K174K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets333K174K792K720K174K
Total Assets18.74M2.82M14.19M31.67M49.14M
Account Payables742K846K821K966K301K
Short-term Debt29K46K18K92K82K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities(29K)013.13M18.94M16.92M
Total Current Liabilities2.11M3.28M17.53M24.12M18.94M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities155K0466K117K0
Total Liabilities2.26M3.28M18M24.24M18.94M
Common Stock15K15K35K114K22K
Retained Earnings(15.94M)(34M)(64.54M)(101.27M)(127.83M)
Accumulated OCI0000(1K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity16.48M(466K)(3.81M)7.43M30.2M
Total Debt335K201K811K773K199K
Net Debt(16.24M)(254K)(8.89M)(25.37M)(29M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$37.4M
Short-term Investments$17.2M
Other Current$9.0M
Total Current Assets$63.5M
PP&E (Net)$861.0K
Total Non-current Assets$861.0K
Total Assets$64.4M

Analysis

Selected assets total $64.4M for Latest. The largest visible component is Cash & Equivalents at $37.4M, about 58.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 29, 2026
3Initial statement of beneficial ownershipOct 1, 2026
8-KCurrent reportSep 29, 2026
8-KCurrent reportSep 28, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

How much cash does UNCY have?

Unicycive Therapeutics, Inc. (UNCY) reported $29.20M in cash and equivalents in fiscal 2025.

How much debt does UNCY carry?

Unicycive Therapeutics, Inc. (UNCY) reported $199,000.00 of total debt, with net debt of -$29.00M.